TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts. 2016

Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, London SE1 9NH, United Kingdom. Electronic address: jill.kucab@kcl.ac.uk.

3-Nitrobenzanthrone (3-NBA) is a highly mutagenic compound and possible human carcinogen found in diesel exhaust. 3-NBA forms bulky DNA adducts following metabolic activation and induces predominantly G:CT:A transversions in a variety of experimental systems. Here we investigated the influence of nucleotide excision repair (NER) on 3-NBA-induced mutagenesis of the human tumour suppressor gene TP53 and the reporter gene lacZ. To this end we utilised Xpa -knockout (Xpa-Null) human TP53 knock-in (Hupki) embryo fibroblasts (HUFs). As Xpa is essential for NER of bulky DNA adducts, we hypothesized that DNA adducts induced by 3-NBA would persist in the genomes of Xpa-Null cells and lead to an increased frequency of mutation. The HUF immortalisation assay was used to select for cells harbouring TP53 mutations following mutagen exposure. We found that Xpa-Null Hupki mice and HUFs were more sensitive to 3-NBA treatment than their wild-type (Xpa-WT) counterparts. However, following 3-NBA treatment and immortalisation, a similar frequency of TP53-mutant clones arose from Xpa-WT and Xpa-Null HUF cultures. In cells from both Xpa genotypes G:CT:A transversion was the predominant TP53 mutation type and mutations exhibited bias towards the non-transcribed strand. Thirty-two percent of 3-NBA-induced TP53 mutations occurred at CpG sites, all of which are hotspots for mutation in smokers' lung cancer (codons 157, 158, 175, 245, 248, 273, 282). We also examined 3-NBA-induced mutagenesis of an integrated lacZ reporter gene in HUFs, where we again observed a similar mutant frequency in Xpa-WT and Xpa-Null cells. Our findings suggest that 3-NBA-DNA adducts may evade removal by global genomic NER; the persistence of 3-NBA adducts in DNA may be an important factor in its mutagenicity.

UI MeSH Term Description Entries
D007763 Lac Operon The genetic unit consisting of three structural genes, an operator and a regulatory gene. The regulatory gene controls the synthesis of the three structural genes: BETA-GALACTOSIDASE and beta-galactoside permease (involved with the metabolism of lactose), and beta-thiogalactoside acetyltransferase. Lac Gene,LacZ Genes,Lactose Operon,Gene, Lac,Gene, LacZ,Genes, Lac,Genes, LacZ,Lac Genes,Lac Operons,LacZ Gene,Lactose Operons,Operon, Lac,Operon, Lactose,Operons, Lac,Operons, Lactose
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
March 2015, Mutation research,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
May 2000, Mutation research,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
November 2019, Methods and protocols,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
April 2012, Environmental and molecular mutagenesis,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
January 2001, Toxicologic pathology,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
November 1999, Carcinogenesis,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
January 2013, Methods in molecular biology (Clifton, N.J.),
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
November 2010, Biochemical and biophysical research communications,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
July 2006, Cancer letters,
Jill E Kucab, and Edwin P Zwart, and Harry van Steeg, and Mirjam Luijten, and Heinz H Schmeiser, and David H Phillips, and Volker M Arlt
June 2010, The FEBS journal,
Copied contents to your clipboard!